IPP Bureau
Digital adoption in healthcare will see exponential growth: Wipro GE study
By IPP Bureau - September 03, 2021
Key trends indicate that AI-based solutions, cloud-based healthcare solutions and digital transformations will be the key in the years to come.
Phase 2 of Covaxin intranasal trials begin in Kanpur
By IPP Bureau - September 02, 2021
The vaccine is designed to neutralise the virus in the nostril itself and prevent it from penetrating deep down into the respiratory tract
Natco Pharma launch Nat-Lenalidomide in Canada
By IPP Bureau - September 02, 2021
Nat-Lenalidomide, a generic alternative to Revlimid, expands affordable treatment options for patients with multiple myeloma and patients with transfusion-dependent anaemia due to myelodysplastic syndromes (MDS)
Reddy-Lenalidomide launched in Canada
By IPP Bureau - September 02, 2021
Dr. Reddy's Laboratories Canada announces the launch of Reddy-Lenalidomide, one of the first generic medications of its kind for the Canadian market
Sun Pharma Industries announce sale of Kayaku
By IPP Bureau - September 02, 2021
The company has been sold to Shinshin Pharmaceuticals
Medtech player Healthium acquires CareNow
By IPP Bureau - September 02, 2021
This is the third acquisition by Healthium this year apart from AbGel business in India and VitalCare in the UK
Medtronic partners with Stasis to enhance patient monitoring in India
By IPP Bureau - September 02, 2021
The Stasis connected care monitoring system includes - a bedside monitor that monitors 6 vital signs, a tablet that enables intuitive monitoring, and the Stasis app that allows for remote monitoring across devices
Janssen announces U.S. FDA approval of Invega Hafyera
By IPP Bureau - September 02, 2021
Invega Hafyera offers patients the fewest doses per year. Phase 3 non-inferiority study results showed over 92% of participants were relapse-free at 12 months
Granules India receive DRDO licence to manufacture and market 2-DG
By IPP Bureau - September 02, 2021
The drug has been granted permission by DCGI for emergency use as an adjunct therapy for Covid-19
Morpen Laboratories to transfer its medical devices business to a wholly owned subsidiary
By IPP Bureau - September 02, 2021
The revenues and profits derived from the new subsidiary will be consolidated in the parent company
Union Minister Mansukh Mandaviya chairs meet on eradicating TB
By IPP Bureau - September 02, 2021
Coordinated and collaborative efforts will strongly contribute to the achievement of shared goals faster: Mandaviya
Shilpa Medicare receives approval for 2-Deoxy-2-Glucose powder
By IPP Bureau - September 01, 2021
The powder is approved for the treatment of adjunct therapy in moderate to severe Covid-19 patients
.jpg "Pharma tops India’s exports from SEZs")
Pharma tops India’s exports from SEZs
By IPP Bureau - September 01, 2021
As of June 30, 2021, 267 out of a total of 427 SEZs approved by the government are operational
.jpeg "Ami Organics bets on strategic acquisitions as its IPO opens on Sept 1")
Ami Organics bets on strategic acquisitions as its IPO opens on Sept 1
By IPP Bureau - September 01, 2021
The company aims to continue its expansion via organic and inorganic routes to increase production capacity and product portfolio
WHO releases compendium of innovative health technologies
By IPP Bureau - September 01, 2021
The Covid-19 pandemic has exposed the divide that exists between rich and developing nations and to address these challenges the World Health Organisation (WHO), has compiled a list of innovative health technologies that aim to bridge the gap
